Work

Figures S1 and S2 from VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma

Year: 2023

Type: other

Abstract: Supplementary Figure S1. Ipi-Bev treatment altered circulating cytokine/chemokine expression. Supplementary Figure S2. Pre-treatment and post-treatment serum levels of IP-10, TNFa, IL-1a, INFa2, GRO, and IL-8 in Ipi-Bev-treated patients.

DOI: 10.1158/2326-6066.22538654

Authors: Xinqi Wu, Anita Giobbie-Hurder, Xiaoyun Liao, Donald Lawrence, David McDermott, Jun Zhou, Scott Rodig, F. Stephen Hodi

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362567106

Cites:

Cited by:

Related to: 10